CDKL5 is a brain MeCP2 target gene regulated by DNA methylation
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Rett syndrome and its "early-onset seizure" variant are severe neurodevelopmental disorders associated with mutations within the MECP2 and the CDKL5 genes. Antidepressants and drugs of abuse induce the expression of the epigenetic factor MeCP2, thereby influencing chromatin remodeling. We show that increased MeCP2 levels resulted in the repression of Cdkl5 in rat brain structures in response to cocaine, as well as in cells exposed to serotonin, or overexpressing MeCP2. In contrast, Cdkl5 was induced by siRNA-mediated knockdown of Mecp2 and by DNA-methyltransferase inhibitors, demonstrating its regulation by MeCP2 and by DNA methylation. Cdkl5 gene methylation and its methylation-dependent binding to MeCP2 were increased in the striatum of cocaine-treated rats. Our data demonstrate that Cdkl5 is a MeCP2-repressed target gene providing a link between genes the mutation of which generates overlapping symptoms. They highlight DNA methylation changes as a potential mechanism participating in the long-term plasticity triggered by pharmacological agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 3×
“Mutations within the X-linked MECP2 gene were found in patients affected by Rett syndrome (RTT) (Amir et al., 1999), a severe neurodevelopmental disorder characterized by various phenotypes such as cognitive impairment, language dysfunction, social withdrawal, motor abnormalities, seizures and…”
BackgroundEpigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse
McGowan, P. O., Sasaki, A., D'Alessio, A. C., Dymov, S., Labonté, B., Szyf, M., Turecki, G., & Meaney, M. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2270 · Cited by 3,531
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501
Chromatin modification and epigenetic reprogramming in mammalian development
Li, E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg887 · Cited by 1,900
Phenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · cited 1×
“…on CpG dinucleotides constitutes a hallmark correlated with transcriptionally silent condensed chromatin (Bird, 2002; Weber et al., 2005) and has been extensively studied during development and cancer progression associated with the inactivation of tumor suppressor genes (Feinberg, 2007).”
BackgroundEpigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 1×
“However, only recently have epigenetic mechanisms been considered as likely involved in psychiatric disorders such as depression or drug addiction (Duman and Newton, 2007; Romieu et al., 2008; Tsankova et al., 2007).”
BackgroundDeficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 1×
“MeCP2 requirement in the final stages of neuronal development and/or function has been demonstrated by using Mecp2 conditional knockout mice (Chen et al., 2001) which exhibit a phenotype similar to that of the human syndrome.”
BackgroundThe Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 2×
“However, the extensive search for genes regulated by MeCP2 has so far identified only a limited number of well characterized targets (Chahrour and Zoghbi, 2007; Cohen et al., 2008).”
BackgroundZhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877
Cited by
Addiction science: Uncovering neurobiological complexity
Volkow, N. D., & Baler, R. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.007 · Cited by 193
“Not surprisingly, investigators are working to identify how drugs remodel chromatin structure to affect the recruitment of transcription factors onto speci fi c gene promoters and how this in fl uences behavior (Carouge et al., 2010; Kumar et al., 2005; Levine et al., 2005; Maze et al., 2010).”
BackgroundLeoncini, S., De Felice, C., Signorini, C., Zollo, G., Cortelazzo, A., Durand, T., Galano, J.-M., Guerranti, R., Rossi, M., Ciccoli, L., et al. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/421624 · Cited by 71
“A close biochemical and genetic relationship exists between MeCP2 and CDKL5 in that the encoded CDKL5 protein is known to be a kinase able to mediate MeCP2 phosphorylation [3] and that CDKL5 has been reported to be a MeCP2-repressed target gene [9].”
BackgroundOxidative stress in Rett syndrome: natural history, genotype, and variants
Leoncini, S., De Felice, C., Signorini, C., Pecorelli, A., Durand, T., Valacchi, G., Ciccoli, L., & Hayek, J. (2011) · Redox Report · doi:10.1179/1351000211y.0000000004 · Cited by 69
Vaher, K., Anier, K., Jürgenson, M., Harro, J., & Kalda, A. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120916137 · Cited by 12
“…levels and promoter methylation status of the A2AR, Ppp1cc, and Taar7b (Figure 7) after the cocaine challenge as several studies have demonstrated that these genes might be important in addiction-related behaviour (Anier et al., 2010; Carouge et al., 2010; Filip et al., 2006; Massart et al., 2015).”
Background
Metadata
- Authors
- Carouge, D., Host, L., Aunis, D., Zwiller, J., & Anglard, P.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 38
- Issue
- 3
- Pages
- 414-424
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2084971062
- Cited by
- 108
- References
- 12
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. https://app.cochat.ai/papers/10.1016/j.nbd.2010.02.014
- The paper
- Carouge, D., Host, L., Aunis, D., Zwiller, J., & Anglard, P. (2010). CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2010.02.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.